Literature DB >> 14530331

T cell development in mice expressing CD1d directed by a classical MHC class II promoter.

Claire Forestier1, Se-Ho Park, Datsen Wei, Kamel Benlagha, Luc Teyton, Albert Bendelac.   

Abstract

CD1d and nonclassical MHC molecules differ markedly from classical MHC ligands in their ability to promote the selection and differentiation of developing T cells. Whereas classical MHC-restricted T cells have a predominantly naive phenotype and a broad TCR repertoire, most other T cells have a memory and/or NKT phenotype with a restricted repertoire. Because the nonclassical ligands selecting these memory-type cells are expressed by bone marrow-derived cells, it has been suggested that the development of large repertoires of naive-type cells was dependent on the classical MHC expression pattern in the thymus cortex, high on epithelial cells and low on cortical thymocytes. We redirected CD1d expression using the classical MHC II Ealpha promoter. pEalpha-CD1d mice lacked memory-type NKT cells, but, surprisingly, they did not acquire the reciprocal ability to select a diverse population of naive CD1d-restricted cells. These findings suggest that, whereas the development of NKT cells is dependent on the pattern of CD1d expression, the absence of a broad, naive CD1d-restricted T cell repertoire may reflect intrinsic limitations of the pool of TCR genes or lipid Ags.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530331     DOI: 10.4049/jimmunol.171.8.4096

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Hepatocellular cancer-derived alpha fetoprotein uptake reduces CD1 molecules on monocyte-derived dendritic cells.

Authors:  Chunlei Li; Baobao Song; Patricia M Santos; Lisa H Butterfield
Journal:  Cell Immunol       Date:  2018-11-01       Impact factor: 4.868

2.  Myeloid cells activate iNKT cells to produce IL-4 in the thymic medulla.

Authors:  Haiguang Wang; Elise R Breed; You Jeong Lee; Lily J Qian; Stephen C Jameson; Kristin A Hogquist
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

3.  Critical role for invariant chain in CD1d-mediated selection and maturation of Vα14-invariant NKT cells.

Authors:  Fenna C M Sillé; Constance Martin; Pushpa Jayaraman; Alissa Rothchild; Gurdyal S Besra; Samuel M Behar; Marianne Boes
Journal:  Immunol Lett       Date:  2011-05-05       Impact factor: 3.685

4.  Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease.

Authors:  Xiufang Weng; Ying He; Lavanya Visvabharathy; Chia-Min Liao; Xiaosheng Tan; Arjun Balakumar; Chyung-Ru Wang
Journal:  J Hepatol       Date:  2017-07-14       Impact factor: 25.083

5.  The vitamin D receptor is required for iNKT cell development.

Authors:  Sanhong Yu; Margherita T Cantorna
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-25       Impact factor: 11.205

6.  Retinoic acid regulates CD1d gene expression at the transcriptional level in human and rodent monocytic cells.

Authors:  Qiuyan Chen; A Catharine Ross
Journal:  Exp Biol Med (Maywood)       Date:  2007-04

7.  All-trans-retinoic acid and CD38 ligation differentially regulate CD1d expression and α-galactosylceramide-induced immune responses.

Authors:  Qiuyan Chen; A Catharine Ross
Journal:  Immunobiology       Date:  2014-09-16       Impact factor: 3.144

Review 8.  Signaling for NKT cell development: the SAP-FynT connection.

Authors:  Christine Borowski; Albert Bendelac
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

9.  The transcriptional repressor NKAP is required for the development of iNKT cells.

Authors:  Puspa Thapa; Joy Das; Douglas McWilliams; Michael Shapiro; Rhianna Sundsbak; Molly Nelson-Holte; Sarah Tangen; Joshua Anderson; Stephen Desiderio; Scott Hiebert; Derek B Sant'angelo; Virginia Smith Shapiro
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Distinct requirements for CD1d intracellular transport for development of V(alpha)14 iNKT cells.

Authors:  Fenna C M Sillé; Mike Boxem; Dave Sprengers; Natacha Veerapen; Gurdyal Besra; Marianne Boes
Journal:  J Immunol       Date:  2009-07-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.